Immunological Diseases

31
Immunological Diseas Immunological Diseas es es Spectrums and Mechanisms Spectrums and Mechanisms Assistant Professor Kiat Ruxrungtham, Assistant Professor Kiat Ruxrungtham, M.D. M.D. Division of Allergy and Clinical Immu Division of Allergy and Clinical Immu nology nology Department of Medicine, Faculty of Me Department of Medicine, Faculty of Me dicine dicine Chulalongkorn University Chulalongkorn University

description

Immunological Diseases. Spectrums and Mechanisms Assistant Professor Kiat Ruxrungtham, M.D. Division of Allergy and Clinical Immunology Department of Medicine, Faculty of Medicine Chulalongkorn University. Principles of Immunology. Key roles of immune responses Terminology - PowerPoint PPT Presentation

Transcript of Immunological Diseases

Page 1: Immunological Diseases

Immunological DiseasesImmunological DiseasesSpectrums and MechanismsSpectrums and Mechanisms

Assistant Professor Kiat Ruxrungtham, M.D.Assistant Professor Kiat Ruxrungtham, M.D.

Division of Allergy and Clinical ImmunologyDivision of Allergy and Clinical ImmunologyDepartment of Medicine, Faculty of MedicineDepartment of Medicine, Faculty of Medicine

Chulalongkorn UniversityChulalongkorn University

Page 2: Immunological Diseases

Principles of Immunology

• Key roles of immune responsesKey roles of immune responses• TerminologyTerminology• Primary and Secondary Immune RespoPrimary and Secondary Immune Respo

nsesnses• Cells and Molecules involvedCells and Molecules involved• Immunological DisordersImmunological Disorders• Mechanisms and Clinical ImplicationsMechanisms and Clinical Implications

Page 3: Immunological Diseases

Key Roles of Immune System• Prevent and control infection• Prevent and control autoimmune diseas

es• Prevent and control malignancy• Prevent and control allergic diseases• Prevent and control graft-versus-host (

GVH)

Page 4: Immunological Diseases

Terminology

• Antigen, allergen, immunogen and epitope

• Innate and Acquired Immunity• Allergy• Autoimmunity, autoimmune diseases

Page 5: Immunological Diseases

Innate and Acquired ImmunityInnate Acquired

Ag specificity no yesMagnitude (10, 20) same higher (20 > 10)Memory no yesKey components PMN, NK T, B lymphocytes

C’, barriers APCs

Page 6: Immunological Diseases

Primary and Secondary ImmuPrimary and Secondary Immune Responsesne Responses

Primary IR7-10relatively lowMostly IgM

relatively high

Secondary IR2-5 daysrelatively highOther class (IgG,

IgA, etc)relatively low

Lag period

Peak response

Ig class

Antigen [ ]

Page 7: Immunological Diseases

Cells and Molecules Involved in Immunology

Innate Immunity• Cells: epithelium, phagocytes (neutrophil

s, monocyte-macrophages) NK cells, mast cells

• Molecules: complement, inflammatory mediators, cytokines, chemokines, adhesion molecules

Page 8: Immunological Diseases

Cells and Molecules Involved in Immunology

Acquired ImmunityAcquired Immunity• CellsCells: APCs (macrophages), T (CD4+, : APCs (macrophages), T (CD4+,

CD8+) and B lymphoctyes (plasma cellsCD8+) and B lymphoctyes (plasma cells), monocytes), monocytes

• MoleculesMolecules: HLA, cytokines, immunoglo: HLA, cytokines, immunoglobulins, adhesion molecules bulins, adhesion molecules

Page 9: Immunological Diseases

Immunological disorders

• Hypersensitivity mediated disorders

• Immunodeficiency : 10 and 20 ID

Page 10: Immunological Diseases

Classification of Hypersensitivity

Gell and Coomb’s Classification: 4 Types• Type 1 : IgE-mediated • Type 2 : Cytotoxic antibodies• Type 3 : Ag-Ab Immune complexes• Type 4 : Delayed-type, cell-mediated

hypersensitivity

Page 11: Immunological Diseases

Type I Hypersensitivity

• Allergen exposure, sensitization and re-exposure

• IgE antibody, mast cells/ basophils and its’ mediators

• Target organ immediate reactions• Clinical allergy: atopic diseases, drug all

ergy, insect allergy and anaphylaxis

Page 12: Immunological Diseases

Pathogenesis of Allergic DiseasePathogenesis of Allergic Disease

Genetic Susceptibility

Allergic Sensitzation

Upper/lower airway or Skinhyperresponsiveness

Allergic Diseases

Allergen Exposure

Adjuvant factors:• Tobacco smoke• Air pollutantsLack of protective factors:• Infection ?• Immunization ?• Nutrition ?

PollutantsInfectionExcercise

Modified from Ulrich Wahn 1998

Vary in spectrum and severity

Page 13: Immunological Diseases

Principle Pathogenesis of Allergic Diseases Principle Pathogenesis of Allergic Diseases

Th-2Th-1

IL-12

IFN-gIL-5IL-3GM-CSF

Eosonophil

Mastcell

IL-4 IgE

B-cell

APCAllergenCD4+ T-cell

Late Phase Reaction

_ +

IgG

Durham and Till 1998, Lu 1998, Drazen 1996

CD8+ cell

AllergyChula

IL-5

B-cell

Allergen

Tryptase, LTs

MBPECP, LTs

Other cells

Page 14: Immunological Diseases

Pathogenesis of Pathogenesis of Allergic DiseasesAllergic Diseases

Cells & MoleculesCells & MoleculesInvolved in Involved in

AllergicAllergicInflammationInflammation

Modified from Modified from Robert DaviesRobert Davies

Page 15: Immunological Diseases

Mediators of Mast Cells and Basophils

Histamine

Tryptase

Chymotryptase

Heparin/Chondroitin

Kininogenase

Chemotactic Factors

ProstaglandinsLeukotrienes

PAFHistamine RFs

IL-3, 4, 5, 6, 7, 8GM-CSF, TNF

Chemokines -MCP1, MIP1

Oxygen radicals

Primary Mediators Secondary Mediators

Sim TC, Grant JA 1996 AllergyChula

Page 16: Immunological Diseases

Mediators of Mast Cells and AllergyMediators of Mast Cells and Allergy

Mast CellMast CellBasophilBasophil

Blood VesselsBlood Vessels

Smooth MusclesSmooth Muscles

Mucus GlandsMucus Glands

Sensory NervesSensory Nerves

LeukocytesLeukocytes

H, PGDH, PGD22, , LTs, PAFLTs, PAF

KininKinin

HH

H, PGDH, PGD22, , LTs, PAFLTs, PAF

LTB4LTB4PAFPAFIL3, IL5IL3, IL5ChemokinesChemokines

Urticaria, AngioedemaUrticaria, AngioedemaLaryngeal edema, ShockLaryngeal edema, Shock

BronchospasmBronchospasmAbd. pain, VomitingAbd. pain, Vomiting

Diarrhea, RhinorheaDiarrhea, RhinorheaBronchial secretionBronchial secretion

ItchingItching

Inflammation - LPAR Inflammation - LPAR

AllergyChula

Page 17: Immunological Diseases

โรคภมแพทพบบอยโรคภมแพทพบบอย โรคภมแพทางจมก โรคภมแพทางจมก Allergic Allergic

RhinitisRhinitis โรคหดจากภมแพ โรคหดจากภมแพ Allergic Asthma Allergic Asthma โรคภมแพทางผวหนง โรคภมแพทางผวหนง Atopic Atopic

DermatitisDermatitis โรคลมพษโรคลมพษ UrticariaUrticaria โรคโรค แพอาหาร แพอาหาร Food AllergyFood Allergy การการแพยาแพยา Drug AllergyDrug Allergy

Allergy Chula 1999

Page 18: Immunological Diseases

Epidemiology of Allergic Diseasesin Thai Children

13

17.9

404.2

13

0 10 20 30 40

Prevalence (%)

AtopicDermatitis

AllergicRhinitis

Asthma1990 1995

พยนต บญญฤทธพงษ และมนตร ตจนดา 2533; ปกต วชยานนท และคณะ 2541

Page 19: Immunological Diseases

Skin Prick TestSkin Prick Test

Page 20: Immunological Diseases

สงแวดลอม กบ โรคภมแพ สงแวดลอม กบ โรคภมแพ

ตวไรฝน ทกกฝนเกสร

ฝนบาน เชอราฝนบนอน สตวเลยง

อาหาร

สงเหลานมอยรอบตวเรา มทงในบานและนอกบาน แตมหลายอยางทเราหลกเลยงได หากเรารวธทถกตอง

Page 21: Immunological Diseases

ควนบหรควนบหรควนธปควนธป

Page 22: Immunological Diseases

Factors Affecting Clinical OutcomesFactors Affecting Clinical Outcomes of Allergic Diseases of Allergic Diseases

AllergyChula

Enivronmental• Allergens• Irritants• Westernization

Infection• Viral• Bacterial

Treatment• Anti-inflammatory• Anti-allergic• Relievers

Compliance• Avoidance• Medication uses

Allergic DiseasesAllergic Diseases

RemissionRemission ModerateMild SevereSevere

Allergen Immunotherapy

Genetic Degree of atopy

Future Therapy ?

Page 23: Immunological Diseases

Clinical Uses of H1 AntagonistsGeneration of Antihistamines

Clinical First Second and Third

Allergic Rhinitis ++ ++ (better compliance)

Urticaria ++ ++ (better compliance)

Atopic dermatitis ++/+++ ++ (better compliance)

Asthma - -/++ (Meta-analysis= NS)URI/NAR ++ -Itching dermatosis ++/+++ ++Anti-motion sickness ++ -Antiemetic ++ -Appetite stimulation++ - (+ for astemizole)

Insomnia ++ -

AllergyChula

Page 24: Immunological Diseases

Treatment of Allergic Rhinitis in AdultsTreatment of Allergic Rhinitis in Adults

Allergy 1994; suppl. 19

Drug Itch/sneezing

Rhinorrhea Blockage Anosmia

Antihistamines +++ ++ + -Topical CS +++ +++ ++ +

Oral CS +++ +++ +++ ++

Topicaldecongestants

- - +++ -

Ipratropiumbromide

- +++ - -

Sodiumcromoclycate

+ + + -

Page 25: Immunological Diseases

Treatment of Allergic Asthma

Allergy 1994; suppl. 19

Treatment Mildintermittant

Mildpersistant

Moderatepersistant

Sverepersistant

Avoidnace + + + +Beta-2Agonist, prn

+ + + +

Inhaled steroid - +/- + +

Long-actingbeta-2 agonist

- no +/- +

Slow releasetheopphylline

- - +/- +

Anti-leukotrienes - + +/- +/-

Page 26: Immunological Diseases

Type II Hypersensitivity• Cytotoxic antibodies: IgG, IgMCytotoxic antibodies: IgG, IgM• Mechanisms of cytolysis: Fix complement and/or Mechanisms of cytolysis: Fix complement and/or

ADCCADCC• Clinical spectrums:Clinical spectrums:

– Autoimmune Hemolytic anemia (AIHA)Autoimmune Hemolytic anemia (AIHA)– ABO Miss-matchedABO Miss-matched– ITPITP

• Stimulatory antibody: Stimulatory antibody: Grave’s diseaseGrave’s disease

• Inhibitory antibody: Inhibitory antibody: Myasthenia gravis (anti-Ach Rc)Myasthenia gravis (anti-Ach Rc)

Page 27: Immunological Diseases

Principle treatments in Type II

• ABO matching• For AIHA, ITP: Steroid, immunosuppres

sive agents, +/- splenectomy

Page 28: Immunological Diseases

Type III Hypersensitivity• Mechanisms: Ag (protein, drugs) + Ab (IgG, I

gM) --> Immune complex --> deposit at subendothelial basement membrane --> fix complement --> chemotaxis ---> PMNs --> vasculitis

• Immune complex diseases:– Serum sickness– Autoimmune diseases: prototype-SLE– Vasculitis

Page 29: Immunological Diseases

Principle treatments in Type III

• Serum sickness: Avoidance of heterogeneous protein injection: ERIG antirabies

• Autoimmune diseases: SLE– Avoidance sun exposure– Steroid– Immunosupressive agents

Page 30: Immunological Diseases

Type IV Hypersensitivity

• Delayed-type cell-mediated reaction• Mechanism: Antigen (contactants) --> s

ensitized T-lymphoctyes --> re-exposure --> T cells activation --> cytokines ---> mononuclear cell recruitment --> DTH

• Clinical disorder: Atopic contact dermatitis

Page 31: Immunological Diseases

Principle treatments in Type IV • Avoidance• Topical steroid• Systemic steroid, if severe